300482.SZ
万孚生物
SZSE · Healthcare · C 制造业 · CN
CNY 16.00
−8.05%Margins
Gross margin
54.8%
EBITDA margin
8.2%
EBIT margin
-12.2%
Net margin
-9.0%
FCF margin
29.6%
-3.0%
Return on equity
-2.5%
Return on assets
-4.1%
Return on invested capital
0.28x
Asset turnover
CNY 830.0M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026